Emerging markets, such as the one in China, saved Philips from a bleak showing in the healthcare marketplace last quarter.
Philips healthcare sales fall in 3Q
Emerging markets, such as the one in China, saved Philips from a bleak showing in the healthcare marketplace last quarter. The growth was not enough to keep the company in the black, however, even just in this sector. Financials released Oct. 12 for 3Q09 show that Philips suffered a 4% decline year-over-year in healthcare sales globally. Leading the trouble areas were declines in the U.S. in imaging systems, clinical care systems, and patient monitoring. Those losses were partially offset by double-digit growth in emerging markets, helping the healthcare business to do better than other Philips businesses. Company-wide sales in the third quarter went down 11% compared to 3Q2008, reflecting continuing weakness in consumer and professional markets. Even so, the company managed a profitability of 6.8% of sales in the quarter, among the highest in recent years. Company execs ascribed the net profit to strong fundamentals and managing costs proactively.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.